Biography:Andrew Gallimore

From HandWiki
Andrew Robert Gallimore
Born1980 or 1981 (age ~46 years)
Other namesAlien Insect
Alma materUniversity of Cambridge
OccupationNeurobiologist, chemist, pharmacologist[1][2]
Years active2005–present
OrganizationOkinawa Institute of Science and Technology;[3][4] Alien Insect
Known forResearch on psychedelic drugs like DMT; DMTx
Notable work
Various books; DMTx
Websitebuildingalienworlds.com
alieninsect.substack.com
noonautics.org

Andrew Robert Gallimore (b. 1980 or 1981; age ~46 years), also known by his handle Alien Insect, is a British neurobiologist, chemist, and pharmacologist who studies psychedelic drugs, particularly dimethyltryptamine (DMT).[5][1][2] He is also a historical scholar of DMT.[5][3][6] Gallimore resides in Japan and works at the Okinawa Institute of Science and Technology.[3][4]

Gallimore and Rick Strassman, author of the 2001 book DMT: The Spirit Molecule, have developed a method of continuous intravenous infusion of DMT that they call "extended-state DMT" or "DMTx".[5][1][3][2][4][7] It can extend the duration of a DMT experience from a few minutes to several hours.[1][3][2][4][7] They intend to use it to study the phenomenology of DMT.[1][3][2][4][7] Other researchers, such as David Nutt, Robin Carhart-Harris, and Matthias Liechti, are also studying DMT by continuous intravenous infusion.[8][9][10]

Gallimore believes that DMT experiences are not simply hallucinations.[5] Instead, he suggests that DMT allows the human brain to interface and interact with a deeper level of reality beyond the physical world.[5][11] Relatedly, Gallimore believes that entity encounters experienced with DMT are real and genuine interactions with beings that he refers to as discarnate intelligent agents.[5][11]

Selected publications

Books

Book chapters

Journal articles

Thesis

  • Gallimore AR (2006). The Biogenesis of Terrestrial and Marine Polycyclic Ethers (PDF) (PhD thesis). University of Cambridge.

See also

References

  1. ↑ 1.0 1.1 1.2 1.3 1.4 Haas, Sarah (19 July 2017). "DMT: Living in an alien world and we don't even know it". https://archives.boulderweekly.com/features/weed-between-the-lines/dmt-living-in-an-alien-world-and-we-dont-even-know-it/. 
  2. ↑ 2.0 2.1 2.2 2.3 2.4 Jarow, Oshan (4 November 2024). "The world's most mysterious psychedelic is already inside your brain". https://www.vox.com/the-highlight/379914/dmt-psychedelics-drug-neuroscience-consciousness-ayahuasca. 
  3. ↑ 3.0 3.1 3.2 3.3 3.4 3.5 Jarnow, Jesse (9 August 2016). "Scientists Developed a Way to Make DMT Trips Last Longer Than Ever". https://www.vice.com/en/article/dmt-trips-last-longer-strassman-gallimore-influence/. 
  4. ↑ 4.0 4.1 4.2 4.3 4.4 John, Graham St (20 March 2018). "Could the brain produce its own psychedelic compound?". https://aeon.co/essays/could-the-brain-produce-its-own-psychedelic-compound. 
  5. ↑ 5.0 5.1 5.2 5.3 5.4 5.5 Hebbert, Sacha (9 May 2023). "Researchers Are Mapping DMT Dimensions Through DMTx Tech". https://psychedelicspotlight.com/researchers-are-mapping-out-new-dimensions-through-dmtx-technology/. 
  6. ↑ Andrew R. Gallimore; David P. Luke (3 July 2015). "DMT Research from 1956 to the Edge of Time". in Luke, David; King, Dave. Neurotransmissions: Essays on Psychedelics from Breaking Convention. London: Strange Attractor Press. pp. 291–316. ISBN 978-1-907222-43-6. https://www.buildingalienworlds.com/uploads/5/7/9/9/57999785/dmt_research_1956_edge_time_arg_dpl_final.pdf. 
  7. ↑ 7.0 7.1 7.2 "A Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic Experience". Front Pharmacol 7: 211. 2016. doi:10.3389/fphar.2016.00211. PMID 27471468. PMC 4944667. https://www.buildingalienworlds.com/uploads/5/7/9/9/57999785/gallimore_strassman_2016_dmt_cont_iv_frontiers_pharm.pdf. 
  8. ↑ "Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants". Transl Psychiatry 13 (1). May 2023. doi:10.1038/s41398-023-02477-4. PMID 37221177. 
  9. ↑ "Psychological and physiological effects of extended DMT". J Psychopharmacol 38 (1): 56–67. January 2024. doi:10.1177/02698811231196877. PMID 37897244. 
  10. ↑ "Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants". Neuropsychopharmacology 50 (6): 1008–1016. May 2025. doi:10.1038/s41386-024-02041-8. PMID 39702577. 
  11. ↑ 11.0 11.1 Gallimore, Andrew R. (1 July 2025) (in English). Death by Astonishment: Confronting the Mystery of the World's Strangest Drug (1st ed.). New York: St. Martin's Press. pp. 213. ISBN 978-1250357755. 




Retrieved from "https://handwiki.org/wiki/index.php?title=Biography:Andrew_Gallimore&oldid=4368432"